Medicxi
Medicxi invests across the full drug development continuum, from early discovery through to late‑stage clinical programs and regulatory approval. The firm focuses on novel, asset‑centric biotech companies that address unmet medical needs with breakthrough therapies. By leveraging its life‑science expertise, Medicxi seeks to create high‑impact health solutions while delivering strong financial returns.
Based on data we found publicly online. Real numbers may be higher.
What they back
Industries
Companies can be in several industries.
Based on data we found publicly online. Real numbers may be higher.
Based on data we found publicly online. Real numbers may be higher.
How they invest
Deal profile
Deal stage and check size data is not available yet.
Based on data we found publicly online. Real numbers may be higher.
Portfolio composition
Companies by founding year
Peak: 2019: 3 companies
Based on data we found publicly online. Real numbers may be higher.
Fund details
Funds
Based on data we found publicly online. Real numbers may be higher.